Svelte Medical Systems
New Providence
About Svelte Medical Systems
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $128.4M
- Funding stage: M&A
- Last round: Series Unknown (May 2021)
- Website: sveltemedical.com
- Phone: +1 908 264 2194
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/svelte-medical-systems-78669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.